NivolumabHypophysitis, primary hypothyroidism and secondary adrenal insufficiency: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1714卷 / 1期

关键词：

D O I：

10.1007/s40278-018-50479-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：299 / 299

相关论文

共 50 条

[1] NivolumabHypophysitis, hypothyroidism and central adrenal insufficiency: case report
Reactions Weekly, 2019, 1770 (1) : 306 - 306
[2] Ipilimumab/nivolumabHypophysitis, hypothyroidism and adrenal insufficiency: case report
Reactions Weekly, 2021, 1852 (1) : 247 - 247
[3] NivolumabHypophysitis leading to secondary adrenal insufficiency: case report
Reactions Weekly, 2021, 1877 (1) : 313 - 313
[4] NivolumabHypophysitis, immune-mediated hypothyroidism and secondary adrenal insufficiency
Reactions Weekly, 2024, 2006 (1) : 540 - 540
[5] NivolumabHyponatraemia secondary to adrenal insufficiency and hypothyroidism: case report
Reactions Weekly, 2021, 1837 (1) : 524 - 524
[6] NivolumabPrimary hypothyroidism and secondary adrenal insufficiency: case report
Reactions Weekly, 2024, 2039 (1) : 443 - 443
[7] PembrolizumabThyroiditis, adrenal insufficiency and primary hypothyroidism: case report
Reactions Weekly, 2018, 1726 (1) : 272 - 272
[8] PembrolizumabSecondary adrenal insufficiency and primary hypothyroidism: case report
Reactions Weekly, 2023, 1975 (1) : 308 - 308
[9] Simultaneous Presentation of Secondary Adrenal Insufficiency and Primary Hypothyroidism due to Pembrolizumab: A Case Report
Khatri, Shivam
Alom, Mulham
Kashfi, Simon
Atallah, Jane
Goswami, Gayotri
JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2023, 11
[10] Ipilimumab/nivolumabHypophysitis and hypothyroidism: case report
Reactions Weekly, 2018, 1696 (1) : 215 - 215

← 1 2 3 4 5 →